161 related articles for article (PubMed ID: 38822039)
21. Mismatch repair deficiency identifies patients with high-intermediate-risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: A prognostic biomarker.
Backes FJ; Haag J; Cosgrove CM; Suarez A; Cohn DE; Goodfellow PJ
Cancer; 2019 Feb; 125(3):398-405. PubMed ID: 30561762
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of LncRNA SCAMP1 suppressed malignant biological behaviours of glioma cells via modulating miR-499a-5p/LMX1A/NLRC5 pathway.
Zong Z; Song Y; Xue Y; Ruan X; Liu X; Yang C; Zheng J; Cao S; Li Z; Liu Y
J Cell Mol Med; 2019 Aug; 23(8):5048-5062. PubMed ID: 31207033
[TBL] [Abstract][Full Text] [Related]
23. Arid2-IR promotes NF-κB-mediated renal inflammation by targeting NLRC5 transcription.
Zhang P; Yu C; Yu J; Li Z; Lan HY; Zhou Q
Cell Mol Life Sci; 2021 Mar; 78(5):2387-2404. PubMed ID: 33090288
[TBL] [Abstract][Full Text] [Related]
24. WTAP facilitates progression of endometrial cancer via CAV-1/NF-κB axis.
Li Q; Wang C; Dong W; Su Y; Ma Z
Cell Biol Int; 2021 Jun; 45(6):1269-1277. PubMed ID: 33559954
[TBL] [Abstract][Full Text] [Related]
25. NLRC5 mediates cell proliferation, migration, and invasion by regulating the Wnt/β-catenin signalling pathway in clear cell renal cell carcinoma.
Wang Q; Ding H; He Y; Li X; Cheng Y; Xu Q; Yang Y; Liao G; Meng X; Huang C; Li J
Cancer Lett; 2019 Mar; 444():9-19. PubMed ID: 30543814
[TBL] [Abstract][Full Text] [Related]
26. NLRC5 potentiates anti-tumor CD8
Zhang J; Guo B; Chen JH; Liu XJ; Zhang JH; Zhu HQ; Wang WY; Tang ZH; Wei B; Cao YX; Zhan L
Transl Oncol; 2023 Oct; 36():101742. PubMed ID: 37531863
[TBL] [Abstract][Full Text] [Related]
27. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis.
Xu T; Ni MM; Xing-Li ; Li XF; Meng XM; Huang C; Li J
Int J Biochem Cell Biol; 2016 Jan; 70():92-104. PubMed ID: 26592197
[TBL] [Abstract][Full Text] [Related]
28. MMR deficient undifferentiated/dedifferentiated endometrial carcinomas showing significant programmed death ligand-1 expression (sp 142) with potential therapeutic implications.
Hacking S; Jin C; Komforti M; Liang S; Nasim M
Pathol Res Pract; 2019 Oct; 215(10):152552. PubMed ID: 31353229
[TBL] [Abstract][Full Text] [Related]
29. NLRC5 deficiency selectively impairs MHC class I- dependent lymphocyte killing by cytotoxic T cells.
Staehli F; Ludigs K; Heinz LX; Seguín-Estévez Q; Ferrero I; Braun M; Schroder K; Rebsamen M; Tardivel A; Mattmann C; MacDonald HR; Romero P; Reith W; Guarda G; Tschopp J
J Immunol; 2012 Apr; 188(8):3820-8. PubMed ID: 22412192
[TBL] [Abstract][Full Text] [Related]
30. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA
Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076
[TBL] [Abstract][Full Text] [Related]
31. NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson's disease models.
Liu Z; Shen C; Li H; Tong J; Wu Y; Ma Y; Wang J; Wang Z; Li Q; Zhang X; Dong H; Yang Y; Yu M; Wang J; Zhou R; Fei J; Huang F
J Neuroinflammation; 2023 Apr; 20(1):96. PubMed ID: 37072793
[TBL] [Abstract][Full Text] [Related]
32. DNA mismatch repair deficiency but not ARID1A loss is associated with prognosis in small intestinal adenocarcinoma.
González I; Goyal B; Xia MD; Pai RK; Ma C
Hum Pathol; 2019 Mar; 85():18-26. PubMed ID: 30381262
[TBL] [Abstract][Full Text] [Related]
33. Rare germline mutation and MSH2-&MSH6 + expression in a double primary carcinoma of colorectal carcinoma and endometrial carcinoma: a case report.
Zhang T; Huang X; Liu W; Ling X; Su Z; Huang M; Che S
Diagn Pathol; 2024 Jan; 19(1):25. PubMed ID: 38297350
[TBL] [Abstract][Full Text] [Related]
34. Innate Immune Molecule NLRC5 Protects Mice From Helicobacter-induced Formation of Gastric Lymphoid Tissue.
Chonwerawong M; Ferrand J; Chaudhry HM; Higgins C; Tran LS; Lim SS; Walker MM; Bhathal PS; Dev A; Moore GT; Sievert W; Jenkins BJ; D'Elios MM; Philpott DJ; Kufer TA; Ferrero RL
Gastroenterology; 2020 Jul; 159(1):169-182.e8. PubMed ID: 32169428
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA LINP1 functions as an oncogene in endometrial cancer progression by regulating the PI3K/AKT signaling pathway.
Zhang XH; Li M; Kang YJ; Xie YQ; Cao YX
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6830-6838. PubMed ID: 31486482
[TBL] [Abstract][Full Text] [Related]
36. MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway.
Xu Q; Ge Q; Zhou Y; Yang B; Yang Q; Jiang S; Jiang R; Ai Z; Zhang Z; Teng Y
EBioMedicine; 2020 Jan; 51():102609. PubMed ID: 31915116
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Methods for Testing Mismatch Repair Status in Endometrial Cancer.
Mendiola M; Heredia-Soto V; Ruz-Caracuel I; Baillo A; Ramon-Patino JL; Escudero FJ; Miguel M; Pelaez-Garcia A; Hernandez A; Feliu J; Hardisson D; Redondo A
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833916
[TBL] [Abstract][Full Text] [Related]
38. Liposomal Curcumin Targeting Endometrial Cancer Through the NF-κB Pathway.
Xu H; Gong Z; Zhou S; Yang S; Wang D; Chen X; Wu J; Liu L; Zhong S; Zhao J; Tang J
Cell Physiol Biochem; 2018; 48(2):569-582. PubMed ID: 30021217
[TBL] [Abstract][Full Text] [Related]
39. A novel NF-κB regulator encoded by circPLCE1 inhibits colorectal carcinoma progression by promoting RPS3 ubiquitin-dependent degradation.
Liang ZX; Liu HS; Xiong L; Yang X; Wang FW; Zeng ZW; He XW; Wu XR; Lan P
Mol Cancer; 2021 Aug; 20(1):103. PubMed ID: 34412652
[TBL] [Abstract][Full Text] [Related]
40. NLRC5 deficiency ameliorates diabetic nephropathy through alleviating inflammation.
Luan P; Zhuang J; Zou J; Li H; Shuai P; Xu X; Zhao Y; Kou W; Ji S; Peng A; Xu Y; Su Q; Jian W; Peng W
FASEB J; 2018 Feb; 32(2):1070-1084. PubMed ID: 29070585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
